Anal Paget’s disease is a rare skin cancer that affects the area around the anus. People with Anal Paget’s disease often notice persistent itching, burning, redness, or eczema-like rashes, and doctors may see flaky, moist, or whitish patches. It tends to be long-lasting and can return, and some cases are linked to deeper cancers of the anus, rectum, or nearby glands. Most people are older adults, and not everyone will have the same experience. Treatment usually involves surgery to remove the affected skin, and care may include topical therapy, laser, or radiation, while outlook depends on stage and whether there is an associated internal cancer.
Overview
Anal paget's diseaseSymptoms
Anal Paget’s disease often starts as a stubborn, itchy, burning rash around the anus that can look like eczema. Early symptoms include redness, flaking, oozing or bleeding, pain with wiping or sitting, and moisture or sores that don’t heal.
Outlook and prognosis
Many living with anal Paget’s disease do well when it’s found early and fully removed, though careful follow-up is key. It can come back locally, and a small number have an associated internal cancer. Regular checkups guide timely treatment and support.
Causes and risk factors
Anal Paget's disease arises from abnormal gland cells in perianal skin. It may be primary or due to spread from nearby cancers (anal, colorectal, urogenital). Risk rises with older age and related cancer history; lifestyle or environmental causes remain unclear.
Genetic influences
Genetics play a limited role in Anal Paget’s disease; most cases are not inherited. It usually develops as a local skin cancer or spreads from nearby glands, not due to family mutations. Rare familial patterns exist, so personal and family history still matter.
Diagnosis
Doctors diagnose Anal Paget's disease with a skin exam and biopsy. Pathologists use special stains to confirm the diagnosis of Anal Paget's disease, and clinicians often screen for related internal cancers with colonoscopy or imaging.
Treatment and drugs
Treatment focuses on completely removing the affected skin and nearby tissue, often with wide local excision or, for deeper spread, more extensive surgery. Doctors may add topical therapies, radiation, or targeted medicines for persistent or advanced Anal Paget’s disease. Regular follow‑up checks help catch recurrences early.
Symptoms
Anal Paget's disease often shows up as a stubborn, eczema-like rash around the anus that doesn’t go away. People may notice persistent itching, burning, and soreness that make sitting or bowel movements uncomfortable. Early symptoms of anal Paget's disease can look like common skin irritation or hemorrhoids, so it’s easy to miss at first. Symptoms vary from person to person and can change over time.
Itching around the anus that keeps returning or never fully goes away. It can be worse at night or after sweating. In anal Paget's disease, over-the-counter creams often don’t fix it.
A stinging or raw sensation around the anus can make sitting or cycling uncomfortable. Pain may flare with wiping or tight clothing.
A red, scaly, or moist patch can appear around the anus, sometimes with clear borders. It may look like eczema or a fungal rash. In anal Paget's disease, the rash tends to linger and slowly enlarge.
The area may ooze or weep, leading to dampness or staining on underwear. Secondary infection can cause crusting or odor.
How people usually first notice Anal paget's disease?
Many people first notice anal Paget’s disease as stubborn, eczema-like irritation around the anus that doesn’t clear with usual creams—itching, burning, redness, or a rash that may ooze or crust. Some develop persistent pain, a feeling of rawness, or small bleeding and notice the skin looks thicker or scaly; doctors may initially treat it as dermatitis or a fungal infection before a biopsy gives the diagnosis. Because the first signs of anal Paget’s disease can mimic common skin problems, it’s often first recognized when symptoms keep returning or spreading despite treatment and a clinician decides to sample the skin.
Types of Anal paget's disease
Anal Paget’s disease is a rare cancer that affects skin cells in and around the anal area. Clinicians often describe them in these categories: primary disease that starts in the skin itself, and secondary disease that spreads from a deeper cancer in nearby glands or the lower rectum. Knowing the types of Anal Paget’s disease helps explain why symptoms and treatment plans can differ. People may notice different sets of symptoms depending on their situation.
Primary cutaneous
The abnormal cells start in the skin of the anal or perianal area. Symptoms often include persistent itching, rash-like redness, or burning that can be mistaken for eczema or hemorrhoids. Early symptoms of Anal Paget’s disease in this type may be subtle and come and go.
Secondary (underlying cancer)
The disease in the skin is linked to a nearby internal cancer, often arising from glands in the anal canal or lower rectum. Symptoms can mirror the skin form but may also include bleeding, discharge, or changes in bowel habits. This variant usually prompts a broader search for the source tumor.
What genetics can tell you about symptoms
Some people with anal Paget’s disease who carry mutations in genes like PIK3CA or KRAS tend to have more persistent itching, eczema-like rashes, or ulcerated lesions around the anus. These changes can drive faster cell growth, which often means wider, itchier, and more recurrent patches.
Causes and risk factors
Anal Paget's disease often starts in gland cells in the skin around the anus, and in some people it is linked to an underlying cancer in the anal canal, rectum, or nearby urinary or genital organs. It is usually not inherited, and the gene changes are acquired in the local skin cells over time. The strongest risks are older age and having or developing cancers of the colon, rectum, or anal canal, and clear lifestyle triggers have not been confirmed. Not everyone with the same risk develops the condition. See a clinician if you are worried about your risks or early symptoms of Anal Paget's disease, because finding any hidden associated cancer early can shape care.
Environmental and biological risk factors
Anal Paget's disease is rare, and this section explains what may raise the chance of developing it. Doctors often group risks into internal (biological) and external (environmental). Below are the main environmental and biological factors linked to a higher chance of this condition. Understanding these factors won’t diagnose early symptoms of Anal Paget's disease, but it can help you decide when to check in with a clinician.
Most cases are found in people over 60. Aging skin and glands may be more vulnerable to the abnormal cell changes involved in this condition.
Perianal Paget's is reported more often in men than in women. Differences in local gland biology may play a role, though the exact reason is unclear.
Paget cells can spread from an underlying anorectal adenocarcinoma into the surface skin. Having a current or prior anal canal or rectal gland-type cancer raises the chance of secondary Anal Paget's disease.
Less often, cancers in the colon, urinary tract, or genital tract occur alongside this disease. Shared gland features may link these conditions biologically.
Genetic risk factors
Genetic influences in Anal Paget's disease mostly involve changes that happen only in the tumor cells, not changes you were born with. When early symptoms of Anal Paget's disease lead to a biopsy, the tissue can be tested to see which genes are altered. These findings can help explain why the disease started and sometimes point to targeted treatment options. Risk is not destiny—it varies widely between individuals.
Not usually inherited: Most people with Anal Paget's disease do not carry a passed-down gene change. The genetic changes arise in the skin cells over time. Family risk is generally low.
HER2 gene changes: Many tumors show extra copies or activating changes in HER2, a growth-signal gene. This can help the disease develop and may influence treatment choices. Testing the tumor for HER2 is common.
PIK3CA pathway: Alterations in PIK3CA and related signals can keep growth pathways overactive. These are acquired in the tumor and are not known to be inherited risks. They may appear alongside HER2 changes.
RAS-RAF signaling: Changes in RAS or RAF genes can push cells to divide more than they should. These are somatic, meaning they are found only in the tumor. Their presence can shape how the disease behaves.
TP53 and repair: Loss of TP53 or other DNA repair controls lets cells build up further mutations. This can contribute to Anal Paget's disease in some cases. These changes are typically tumor-only.
Gene regulators: Mutations in genes that control how DNA is packaged, such as KMT2C or KMT2D, are reported. They can alter which genes switch on or off in the tumor. Their role seems supportive rather than the sole driver.
Secondary disease: When Anal Paget's disease is secondary to a nearby cancer, the same genetic changes from the internal tumor often appear in the skin. This reflects spread of those cancer cells rather than a separate inherited risk. Doctors may evaluate for an underlying malignancy.
Lifestyle risk factors
Anal Paget's disease is rare, and strong evidence for specific lifestyle risk factors is limited. Most known risks relate to age and associated cancers, but day-to-day habits can still influence skin health, symptom recognition, and timeliness of care. Below are potential lifestyle risk factors for Anal Paget's disease and habits that may affect detection or progression. These points focus on how lifestyle affects Anal Paget's disease and use the long-tail term lifestyle risk factors for Anal Paget's disease when appropriate.
Tobacco exposes tissues to carcinogens and impairs local immune defense. In people with anorectal conditions, smoking is linked to delayed healing and may complicate management of Paget’s lesions.
High alcohol intake can dampen immune surveillance and increase systemic inflammation. This may worsen skin irritation and delay recovery after procedures for Anal Paget’s disease.
Excess weight increases moisture and friction in the perianal folds. Persistent maceration and chafing can mask early Paget’s plaques and facilitate secondary infections that obscure diagnosis.
Prolonged moisture, irritant wipes, and harsh soaps can disrupt the skin barrier. This may intensify itching or redness and make Anal Paget’s disease harder to distinguish from dermatitis, delaying evaluation.
Risk prevention
Anal Paget's disease is rare, and while there’s no sure way to prevent it, you can lower the chance of a late diagnosis by staying alert to skin changes and keeping up with routine care. Screenings and check-ups are part of prevention too. Noticing early symptoms of Anal Paget's disease—like a persistent, eczema-like rash, burning, or itching around the anus—can lead to earlier evaluation and treatment. Steps that reduce chronic irritation and support healthy skin can also help you spot new changes sooner.
Follow your country’s colorectal cancer screening schedule (often starting in midlife). This can uncover related issues in the colon or rectum that sometimes accompany Anal Paget's disease.
See a clinician if perianal itching, burning, redness, or a rash lasts more than a few weeks. Early assessment helps distinguish common irritation from Anal Paget's disease.
During bathing, glance at the skin around the anus for new redness, scaling, or sores. If something doesn’t improve, arrange a medical review.
Keep the area dry with breathable underwear and change out of sweaty clothes promptly. Use barrier creams if you have leakage or incontinence to protect skin from constant moisture.
Transmission
Anal Paget’s disease is not an infection, so it cannot be passed from person to person. Questions about how this condition spreads are common, but it does not spread through sex, casual skin contact, bathrooms, shared towels, or blood. Instead, it typically begins in the skin glands around the anus, and in some people it is linked to a nearby cancer in the anal canal or rectum that extends to the skin. It is not known to run in families, and there is no established genetic transmission of Anal Paget’s disease.
When to test your genes
Consider genetic testing if you have multiple close relatives with Paget’s disease of bone, early-onset disease, or unusually aggressive or recurrent Paget’s, as certain inherited variants (like SQSTM1) can raise risk. Testing can guide earlier monitoring, targeted therapies, and screening for relatives. Discuss timing with a genetics professional.
Diagnosis
For many, the first clues are a stubborn, itchy rash or burning around the anus that looks like eczema but never quite clears. Doctors usually begin with a close look at the skin and a careful review of symptoms before ordering tests. The diagnosis of Anal Paget's disease is confirmed with tissue sampling and then broadened to check for any related cancers in nearby organs. Some diagnoses are clear after a single visit, while others take more time.
Your clinician asks about itch, burning, bleeding, and how long the rash has persisted. They examine the perianal skin and nearby lymph nodes, looking for subtle color or texture changes. This helps decide which tests to do first.
A gentle rectal exam and a look inside the anal canal can reveal hidden lesions. These exams help determine if disease extends inward or if another cause explains symptoms. Findings guide where to biopsy.
A small sample of skin is removed to look for Paget cells under the microscope. This confirms the condition and rules out look‑alikes like eczema or fungal infection. Results shape the treatment plan.
Pathology labs use immunostains and mucin stains to confirm Paget cells and distinguish primary skin disease from spread of another cancer. This distinction matters because treatment and follow‑up differ. Your provider may suggest additional tests to look closer.
Stages of Anal paget's disease
Anal Paget's disease can stay limited to the skin for a long time or, less commonly, grow deeper and spread to lymph nodes or other organs. Early symptoms of anal Paget's disease often look like common skin problems around the anus—itching, burning, or a scaly rash—so it can be missed at first. Many people feel reassured knowing what their tests can—and can’t—show. Doctors stage it by how deep the cells go and whether nearby nodes or distant sites are involved.
In situ disease
Abnormal cells are only in the top layer of skin. In anal Paget's disease, this means no deeper invasion or spread.
Local invasion
Cells grow below the surface into the dermis or nearby glands. This can cause thicker patches, nodules, or sores that don’t heal.
Regional lymph nodes
Disease has spread to nearby lymph nodes, usually in the groin. You may notice firm lumps, and imaging or biopsy helps confirm spread.
Distant metastasis
Cells have traveled to organs such as liver, lung, or bone. Symptoms vary by location, and treatment usually includes systemic therapy.
Outlook and prognosis
Looking ahead can feel daunting, but most people with Anal Paget’s disease do well when it’s found early and fully removed. This condition tends to stay on the skin surface at first, causing itching, burning, or a rash that looks like eczema. The main concern is that it can recur in the same area, especially if the initial margins weren’t clear. Over time, most people need careful skin and rectal exams, and sometimes mapping biopsies, to catch small spots before they grow.
Doctors call this the prognosis—a medical word for likely outcomes. Early symptoms of Anal Paget’s disease can be subtle, which sometimes delays diagnosis and raises the chance of spread into deeper layers or nearby lymph nodes. When the disease is limited to the skin (in situ), long‑term survival is excellent, but repeat treatments may be needed. If it invades deeper tissues or is linked with an underlying cancer of the anal canal, rectum, or nearby glands, the outlook is more guarded and treatment may include surgery, radiation, and systemic therapy.
Everyone’s journey looks a little different. Reported mortality is low for skin‑limited disease, but higher when there is invasion or nodal involvement; this is why ongoing follow‑up is so important. Recurrence often happens in the first few years, then becomes less likely, though late recurrences can occur. Talk with your doctor about what your personal outlook might look like, including your pathology details, margin status, and whether any associated cancers were ruled out.
Long-term effects
Anal Paget's disease is a rare skin cancer around the anus that tends to come back locally and may link to a deeper rectal cancer. Over time, people may deal with ongoing skin discomfort, changes in bowel control, and the impact of repeated treatments. Long-term effects vary widely, depending on how deep the disease goes and whether lymph nodes are involved. Because early symptoms of anal Paget's disease can be subtle and mistaken for common rashes, some are diagnosed later, which can shape the long-term outlook.
The disease often returns in the same area after surgery or other treatment. New patches can appear months or years later and may need more procedures.
Ongoing itching, burning, or soreness around the anus can persist even after treatment. Flare-ups may come and go and affect sitting, walking, or hygiene.
Some people develop urgency or leakage (fecal incontinence) over time. This can follow surgery, radiation, or scarring in the anal canal.
Scar tissue can tighten the anal opening and make bowel movements painful or difficult. Straining and constipation may become more frequent.
How is it to live with Anal paget's disease?
Living with anal Paget’s disease often means juggling appointments, skin care, and uncertainty about symptoms that can look like common rashes yet need specialist attention. Daily life may involve managing itching, burning, or discomfort when sitting, walking, or using the bathroom, plus dealing with treatments or procedures and follow-up checks to watch for recurrence. People close to you may help with practical tasks and emotional support, and they can feel the stress of waiting for biopsy results or surgery outcomes too. Many find that clear communication with their care team, planning for comfort, and leaning on support networks makes day-to-day life more manageable.
Treatment and drugs
Treatment for anal Paget’s disease usually involves surgery to remove the affected skin and any nearby tissue with cancer cells. Because the area is delicate and recurrence can happen, doctors often use careful mapping and may recommend additional procedures if margins aren’t clear. Radiation therapy can be considered when surgery isn’t possible or to help lower the risk of the disease coming back, and in some cases, topical chemotherapy creams or systemic drugs are used for disease that has spread or isn’t fully removable. Treatment plans often combine several approaches. Keep track of how you feel, and share this with your care team.
Non-drug treatment
Anal Paget's disease is usually managed with procedures rather than pills. Because early symptoms of Anal Paget's disease can look like common rashes, care is often coordinated by colorectal surgeons and dermatology specialists. Non-drug treatments often lay the foundation for long-term control and comfort. Your team will tailor options to the size, depth, and whether cancer cells are only in the skin or linked to a deeper tumor.
A surgeon removes the visible patch along with a rim of healthy-looking skin to lower the risk of missed cells. This is a common first-line approach for Anal Paget's disease.
Thin layers are removed and checked under the microscope in real time until the edges are clear. This tissue-sparing method can help preserve function around the anus.
Targeted beams treat the area when surgery is not possible or when cancer cells remain after surgery. It can also help with symptom control in Anal Paget's disease.
A focused laser vaporizes shallow, scattered spots on the skin’s surface. It may be used for small recurrences or when excision would remove too much tissue.
Your genes may have an impact on how drugs work for you
Some medicines used for anal Paget’s disease, like certain chemotherapies or pain treatments, work differently depending on your genes, which affect how fast your body activates or clears a drug. Genetic testing can sometimes guide dosing or drug choice to improve safety and benefit.
Pharmacological treatments
Medicines for anal Paget’s disease are usually used alongside procedures like surgery, but they can help control patches on the skin and ease symptoms such as itching or burning. Options include prescription creams, light-activated treatments, and, in advanced cases, targeted drugs or chemotherapy. These choices depend on how deep the disease goes, whether it has spread, and specific features found on tumor testing. Not everyone responds to the same medication in the same way.
This immune-activating cream can shrink surface lesions and ease itching when used several times a week over weeks to months. Redness, burning, or soreness at the application site are common and often signal the medicine is working.
This chemotherapy cream may help treat superficial disease or small recurrences after surgery. It can cause stinging, peeling, and inflammation that usually settle once treatment cycles pause.
A light‑sensitizing cream (such as aminolevulinic acid) is applied to the area and then activated with a special light to destroy abnormal cells. It can help when surgery is not possible or for limited surface areas, but repeat sessions may be needed.
If the tumor tests HER2‑positive, drugs like trastuzumab (sometimes with pertuzumab) may slow or shrink advanced disease. These are given by infusion and may require heart function monitoring.
Genetic influences
Anal Paget’s disease is rarely tied to inherited risk; most cases develop because of gene changes that occur over time in the cells of the affected area. Family history is one of the strongest clues to a genetic influence, but for anal Paget’s disease this is uncommon. When genetics are involved, doctors are usually studying the tumor’s DNA to understand how it behaves, rather than looking for a gene change you were born with. Changes in a gene called HER2, and in other growth-control pathways, are found in some tumors and can sometimes point to targeted treatment options.
Because anal Paget’s disease can occasionally be “secondary” to a nearby cancer in the rectum, colon, or urinary tract, a strong family history of colon or uterine cancer may prompt a discussion about genetic counseling for inherited conditions such as Lynch syndrome. If testing is recommended, it’s typically tumor profiling to guide therapy rather than genetic testing for anal Paget’s disease risk.
Is Anal paget's disease genetic?
Genetics play a limited role in Anal Paget’s disease; most cases are not inherited. It usually develops as a local skin cancer or spreads from nearby glands, not due to family mutations. Rare familial patterns exist, so personal and family history still matter.
Pharmacogenetics—how genetics influence drug effects
For Anal Paget's disease, genetics can guide both drug choice and dosing, especially when surgery isn’t enough or the disease returns. Testing the tumor for changes like extra copies of HER2 can sometimes open the door to targeted medicines that home in on that change. If chemotherapy such as fluoropyrimidines (5-FU or capecitabine) is used, a gene called DPYD can affect how safely your body handles these drugs; certain results call for lower doses or choosing a different medicine. Genetic testing can sometimes identify how your body processes medicine, which helps reduce severe side effects and improve benefit. Other inherited differences, such as UGT1A1 variants when irinotecan is considered, may also guide dosing to lower the risk of low white blood cells. Taken together with your medical history and goals, these genetic and tumor test results help doctors personalize therapy. In short, pharmacogenetic testing for Anal Paget's disease is one tool your team may use to match the right medicine and dose to you.
Interactions with other conditions
Anal Paget's disease can occur alongside cancers in nearby organs, especially the rectum or colon and, in some people, the bladder, prostate, or gynecologic organs, so doctors often recommend screening to look for any hidden tumors. It may also show up with other skin problems, and chronic scratching or skin infections can flare when the area is inflamed. Having more than one diagnosis can make symptoms feel harder to untangle. Because early symptoms of Anal Paget's disease—such as itching, burning, or a rash—can resemble eczema, psoriasis, or hemorrhoids, these overlaps sometimes delay recognition and treatment. When surgery or topical treatments are needed, conditions like diabetes, blood vessel disease, or a weakened immune system can slow wound healing and raise the risk of infection. If Anal Paget's disease is found, your care team will usually check for related colorectal or urogenital cancers and coordinate follow-up, since treating all linked conditions together tends to improve outcomes.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Community stories often described the condition as a stubborn, itchy rash that wouldn’t clear despite creams and careful hygiene. Some remembered sitting gingerly on hard chairs, or waking at night to scratch, only to be told it was “just eczema.” In clinics, doctors saw a red, scaly patch around the anus that looked like dermatitis or a fungal infection. For many living with Anal Paget’s disease, this everyday mix-up delayed the right diagnosis.
First described in the medical literature as a skin problem that mimicked common rashes, Anal Paget’s disease was initially understood only through symptoms, later linked to abnormal gland-like cells in the skin. As microscopes improved and tissue staining advanced, pathologists noticed that these cells resembled those in certain sweat glands and, at times, in cancers of the lower bowel. From early theories to modern research, the story of Anal Paget’s disease shows how careful observation, then lab techniques, reshaped our understanding.
In the early 20th century, clinicians began to separate cases limited to the skin from those tied to an underlying tumor in the rectum or nearby glands. This mattered for treatment. People with disease confined to the skin often needed surgery focused on the affected area. Those with deeper or linked disease required broader evaluation—colonoscopy, imaging—and more extensive treatment. Over time, descriptions became clearer about patterns, such as slow spread along the skin surface and a tendency to recur if the edges weren’t fully removed.
In recent decades, awareness has grown that Anal Paget’s disease is uncommon but likely underrecognized because it looks like everyday skin conditions. Dermatologists and colorectal specialists now work together, using targeted biopsies and special stains to confirm the diagnosis and check for any hidden source. This team approach emerged as case reports and series accumulated, showing that thorough evaluation at the start can shape outcomes years later.
Advances in genetics and cell markers refined the picture further. Certain proteins on the cell surface, seen under the microscope, help distinguish Anal Paget’s disease from other rashes and point to whether the disease starts in the skin or extends from the bowel. While these tools feel technical, they made real-world care more precise—fewer missed diagnoses, better mapping of the affected area, and more tailored surgery or topical treatments.
Looking back helps explain why many people with Anal Paget’s disease still face delayed diagnosis. The condition hides in plain sight, wearing the face of common rashes. Knowing the condition’s history reminds clinicians to keep it in mind when a “rash” around the anus lingers for months, burns, itches, or returns after treatment. Each stage in history has added to the picture we have today, bringing earlier recognition and more focused care.